Do pulmonary drugs increase mortality in patients with heart failure? Data from a primary care registryRutten, F HWarnier, M JVan Mourik, YBertens, LHoes, A W
Drugs proved to reduce mortality in chronic congestive heart failure include all of the followings EXCEPTA.captoprilB.carvedilolC.digoxinD.enalaprilE.spironolactone的答案是什么.用刷刷题APP,拍照搜索答疑.刷刷题(shuashuati.com)是专业的大学职业搜题找答案,刷
Pathophysiology of Heart Failure:To improve the life qualityDecrease hospitalization and the mortality.Basic Pharmacology of 11、Drugs Used in Heart FailureTreatment is therefore directed at two somewhat different goals: (1) reducing symptoms and slowing progression as much as possible during relatively...
Acute heart failure (AHF) is a major burden disease, with a complex physiopathology, unsatisfactory diagnosis, treatment and a very poor prognosis. In the last two decades, a number of drugs have progressed from preclinical to early and late clinical development, but only a few of them have ...
Treatment-related MortalityIncreased mortality reported in patients with multiple myeloma receiving pembrolizumab in combination with a thalidomide analogue and dexamethasone.Patients with multiple myeloma should not receive an anti-programmed death receptor-1 (anti-PD-1) or anti-programmed-death ligand-1 ...
Heart failure or Heart rhythm problems or Hypotension (low blood pressure) or Hypovolemia (decrease in blood volume) or Ischemic heart disease, history of or Trouble with swallowing—Use with caution. May cause side effects to become worse. Phenylketonuria...
In a trend contrary to most malignancies, both incidence and mortality continue to rise due to pancreatic cancer. The majority of patients present with advanced disease and there are no treatment options for this stage that have demonstrated a median survival > 1 year. As the penultimate step ...
mutant TTR proteins, formulated as a lipid nanoparticle (LNP). A pivotal trial evaluating the safety and efficacy of ONPATTRO® demonstrated its ability to reduce efficiently and rapidly TTR protein levels in patients and improve significantly the neurological manifestations of the disease as well ...
Treatment for cardiovascular disease aims to reduce morbidity and mortality and to improve patient quality of life. The properly designed randomized controlled trial is recognized as providing the highest level of evidence in determining guidelines for therapeutic practice [1]. However, the evidence for...
Gastric cancer (GC) is one of the major causes of death worldwide, ranking as the fifth most incident cancer in 2020 and the fourth leading cause of cancer mortality. The majority of GC patients are in an advanced stage at the time of diagnosis, presenti